We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/6/2019 09:06 | Interesting price action in the last few minutes, in the face of someone still apparently off-loading substantial holdings? | tightfist | |
27/6/2019 08:57 | gary38 - at least your last post #103 made me chuckle. To be fair the chart does look to have been in a downward trend for a while, BUT I can't see any reason for the share price to keep falling. The share price does look to have turned a corner (shrewdie #100) with a bit of momentum in the last couple of days. Reflecting the RNSs. I really have trouble believing charts are any use on an AIM share like Opti; especially in isolation. They do sometimes show a classic pattern, but this is often only in retrospect. And, with respect to the poster(s?) who identified the flag, which was (is) clearly identifiable on the chart, that does look a bit droopy now. Just to add, I am not an expert by any means. This is all just my opinion. | m4rtinu | |
27/6/2019 08:47 | Shrewdie,I am looking for more signs of goetzpartners clients buying. | parob | |
27/6/2019 08:40 | Gary38 oh dear you even seem to struggle with the English Language,poor chap what chance have you at being a successful investor. | scotty1 | |
27/6/2019 08:32 | Plus he posts misleading dangerous lies. The one that was the tipping point for me was the insistence that a phase I and phase II trial would have to be done on LPLDL. This is an outright untruth because of the FDA GRAS status but he refuses to accept facts. Nobbygnome, you know and I know, that that GRAS status means it is safe as an additive to food. But it needs GRAS/E for it to be classed as effective. | rayrac | |
27/6/2019 08:31 | Tests results are poor,does not work on patients that are awake,terrible,back to 60p | gary38 | |
27/6/2019 08:17 | You obviously are losing a lot of money as you dont use charts.This share will fall back to 60p and could drop to 50p when results of test are poor. | gary38 | |
27/6/2019 08:14 | Strong bounce off a double bottom Rising trend New research investment bank that will issue a buy note. 60p target by Gaz . Filtered The next time 60p gets mentioned will be £1 in from of it. I’m in for more as soon as the funds arrive just hope I don’t miss the rise. Definitely some paid bashing going on now but as ever I just add them to filter. | shrewdmole | |
27/6/2019 08:04 | I would suggest that you don't use charts to make your investment decisions gary38 because you obviously have no idea. | scotty1 | |
27/6/2019 08:04 | Hilarious :) 🤣🤣 | judijudi | |
27/6/2019 08:02 | Chart showing weakness 60p support is not that strong and if price falls through 60p could go as far as 50p. | gary38 | |
27/6/2019 00:40 | Becoming a mess isn’t it. | jamesrs1 | |
26/6/2019 21:18 | Another one for the filter | gary hindsight | |
26/6/2019 21:09 | back to 60p | gary38 | |
26/6/2019 20:49 | nobbygnome - good to see you've taken my comments on board. Not. | lord loads of lolly | |
26/6/2019 20:00 | BTW he is a little older than 55.... | nobbygnome | |
26/6/2019 19:59 | It would be so funny if rayrac got done for misrepresenting facts (aka lying). There is undoubtedly a lot of evidence. We live in hope and if I was him, I think I would stop posting... | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions